Q9WTQ1
Gene name |
Prkd1 (Pkcm, Pkd, Prkcm) |
Protein name |
Serine/threonine-protein kinase D1 |
Names |
EC 2.7.11.13 , Protein kinase C mu type , Protein kinase D , nPKC-D1 , nPKC-mu |
Species |
Rattus norvegicus (Rat) |
KEGG Pathway |
rno:85421 |
EC number |
2.7.11.13: Protein-serine/threonine kinases |
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
589-845 (Protein kinase domain) |
Relief mechanism |
PTM |
Assay |
|
Accessory elements
732-754 (Activation loop from InterPro)
Target domain |
589-845 (Protein kinase domain) |
Relief mechanism |
|
Assay |
|
Autoinhibited structure

Activated structure

1 structures for Q9WTQ1
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q9WTQ1-F1 | Predicted | AlphaFoldDB |
2 variants for Q9WTQ1
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs3320766593 | 259 | V>I | No | EVA | |
rs105305578 | 368 | E>D | No | EVA |
No associated diseases with Q9WTQ1
25 regional properties for Q9WTQ1
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Protein kinase domain | 845 - 1173 | IPR000719 |
domain | Serine-threonine/tyrosine-protein kinase, catalytic domain | 845 - 1169 | IPR001245 |
conserved_site | Tyrosine-protein kinase, receptor class III, conserved site | 904 - 917 | IPR001824 |
domain | Immunoglobulin subtype 2 | 243 - 317 | IPR003598-1 |
domain | Immunoglobulin subtype 2 | 347 - 406 | IPR003598-2 |
domain | Immunoglobulin subtype 2 | 569 - 660 | IPR003598-3 |
domain | Immunoglobulin subtype 2 | 690 - 755 | IPR003598-4 |
domain | Immunoglobulin subtype | 36 - 133 | IPR003599-1 |
domain | Immunoglobulin subtype | 143 - 225 | IPR003599-2 |
domain | Immunoglobulin subtype | 237 - 328 | IPR003599-3 |
domain | Immunoglobulin subtype | 341 - 419 | IPR003599-4 |
domain | Immunoglobulin subtype | 430 - 552 | IPR003599-5 |
domain | Immunoglobulin subtype | 563 - 673 | IPR003599-6 |
domain | Immunoglobulin subtype | 684 - 766 | IPR003599-7 |
domain | Immunoglobulin-like domain | 30 - 111 | IPR007110-1 |
domain | Immunoglobulin-like domain | 219 - 326 | IPR007110-2 |
domain | Immunoglobulin-like domain | 331 - 415 | IPR007110-3 |
domain | Immunoglobulin-like domain | 422 - 552 | IPR007110-4 |
domain | Immunoglobulin-like domain | 555 - 671 | IPR007110-5 |
domain | Immunoglobulin-like domain | 678 - 764 | IPR007110-6 |
active_site | Tyrosine-protein kinase, active site | 1033 - 1045 | IPR008266 |
domain | Immunoglobulin I-set | 678 - 765 | IPR013098 |
binding_site | Protein kinase, ATP binding site | 851 - 879 | IPR017441 |
domain | Tyrosine-protein kinase, catalytic domain | 845 - 1169 | IPR020635 |
domain | VEGFR-2, transmembrane domain | 770 - 804 | IPR041348 |
Functions
Description | ||
---|---|---|
EC Number | 2.7.11.13 | Protein-serine/threonine kinases |
Subcellular Localization |
|
|
PANTHER Family | ||
PANTHER Subfamily | ||
PANTHER Protein Class | ||
PANTHER Pathway Category | No pathway information available |
12 GO annotations of cellular component
Name | Definition |
---|---|
autophagosome membrane | The lipid bilayer surrounding an autophagosome, a double-membrane-bounded vesicle in which endogenous cellular material is sequestered. |
cell cortex | The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins. |
cell-cell junction | A cell junction that forms a connection between two or more cells of an organism; excludes direct cytoplasmic intercellular bridges, such as ring canals in insects. |
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
Golgi apparatus | A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways. |
membrane | A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
perinuclear region of cytoplasm | Cytoplasm situated near, or occurring around, the nucleus. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
trans-Golgi network | The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum, from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination. |
Z disc | Platelike region of a muscle sarcomere to which the plus ends of actin filaments are attached. |
10 GO annotations of molecular function
Name | Definition |
---|---|
ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
diacylglycerol-dependent serine/threonine kinase activity | Catalysis of the reaction |
heat shock protein binding | Binding to a heat shock protein, a protein synthesized or activated in response to heat shock. |
identical protein binding | Binding to an identical protein or proteins. |
kinase activity | Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule. |
metal ion binding | Binding to a metal ion. |
protein kinase activity | Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction |
protein kinase C binding | Binding to protein kinase C. |
protein serine kinase activity | Catalysis of the reactions |
protein serine/threonine kinase activity | Catalysis of the reactions |
47 GO annotations of biological process
Name | Definition |
---|---|
angiogenesis | Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. |
apoptotic process | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
cell differentiation | The cellular developmental process in which a relatively unspecialized cell, e.g. embryonic or regenerative cell, acquires specialized structural and/or functional features that characterize a specific cell. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. |
cellular response to amino acid starvation | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of amino acids. |
cellular response to angiotensin | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an angiotensin stimulus. Angiotensin is any of three physiologically active peptides (angiotensin II, III, or IV) processed from angiotensinogen. |
cellular response to endothelin | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an endothelin stimulus. Endothelin is any of three secretory vasoconstrictive peptides (endothelin-1, -2, -3). |
cellular response to hydroperoxide | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydroperoxide stimulus. Hydroperoxides are monosubstitution products of hydrogen peroxide, HOOH. |
cellular response to norepinephrine stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a norepinephrine stimulus. Norepinephrine is a catecholamine that has the formula C8H11NO3; it acts as a hormone, and as a neurotransmitter in most of the sympathetic nervous system. |
cellular response to organic cyclic compound | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus. |
cellular response to oxidative stress | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals. |
cellular response to phorbol 13-acetate 12-myristate | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a phorbol 13-acetate 12-myristate stimulus. |
cellular response to vascular endothelial growth factor stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus. |
defense response to Gram-negative bacterium | Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism. |
Golgi organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the Golgi apparatus. |
Golgi vesicle transport | The directed movement of substances into, out of or within the Golgi apparatus, mediated by vesicles. |
inflammatory response | The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
innate immune response | Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. |
intracellular signal transduction | The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
nervous system development | The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state. |
phospholipase C-activating G protein-coupled receptor signaling pathway | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation of phospholipase C (PLC) and a subsequent increase in the intracellular concentration of inositol trisphosphate (IP3) and diacylglycerol (DAG). |
positive regulation of angiogenesis | Any process that activates or increases angiogenesis. |
positive regulation of autophagy | Any process that activates, maintains or increases the rate of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm. |
positive regulation of blood vessel endothelial cell migration | Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels. |
positive regulation of canonical NF-kappaB signal transduction | Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling. |
positive regulation of cell size | Any process that increases cell size. |
positive regulation of endothelial cell chemotaxis | Any process that activates or increases the frequency, rate or extent of endothelial cell chemotaxis. |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway | The series of molecular signals initiated by the binding of a vascular endothelial growth factor (VEGF) to its receptor on the surface of a cell, which activates or increases the frequency, rate or extent of endothelial cell chemotaxis. |
positive regulation of endothelial cell migration | Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium. |
positive regulation of endothelial cell proliferation | Any process that activates or increases the rate or extent of endothelial cell proliferation. |
positive regulation of gene expression | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
positive regulation of neuron projection development | Any process that increases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites). |
positive regulation of NF-kappaB transcription factor activity | Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB. |
positive regulation of NLRP3 inflammasome complex assembly | Any process that activates or increases the frequency, rate or extent of NLRP3 inflammasome complex assembly. |
positive regulation of osteoblast differentiation | Any process that activates or increases the frequency, rate or extent of osteoblast differentiation. |
positive regulation of peptide hormone secretion | Any process that increases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules. |
positive regulation of peptidyl-serine phosphorylation | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine. |
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B. |
positive regulation of protein export from nucleus | Any process that activates or increases the frequency, rate or extent of directed movement of proteins from the nucleus into the cytoplasm. |
positive regulation of protein import into nucleus | Any process that activates or increases the frequency, rate or extent of movement of proteins from the cytoplasm into the nucleus. |
positive regulation of sarcomere organization | Any process that increases the rate, frequency or extent of myofibril assembly by organization of muscle actomyosin into sarcomeres. The sarcomere is the repeating unit of a myofibril in a muscle cell, composed of an array of overlapping thick and thin filaments between two adjacent Z discs. |
positive regulation of transcription by RNA polymerase II | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
protein autophosphorylation | The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation). |
regulation of keratinocyte proliferation | Any process that modulates the rate, frequency or extent of keratinocyte proliferation. Keratinocyte proliferation is the multiplication or reproduction of keratinocytes, resulting in the expansion of a cell population. |
regulation of release of sequestered calcium ion into cytosol | Any process that modulates the frequency, rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria. |
regulation of skeletal muscle contraction by modulation of calcium ion sensitivity of myofibril | Any process that modulates the frequency, rate or extent of skeletal muscle contraction by changing calcium ion binding affinity of the myofibril. |
response to norepinephrine | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a norepinephrine stimulus. Norepinephrine is a catecholamine that has the formula C8H11NO3; it acts as a hormone, and as a neurotransmitter in most of the sympathetic nervous system. |
vascular endothelial growth factor receptor signaling pathway | The series of molecular signals initiated by a ligand binding to a vascular endothelial growth factor receptor (VEGFR) on the surface of the target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
8 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
O94806 | PRKD3 | Serine/threonine-protein kinase D3 | Homo sapiens (Human) | SS |
Q9BZL6 | PRKD2 | Serine/threonine-protein kinase D2 | Homo sapiens (Human) | SS |
Q15139 | PRKD1 | Serine/threonine-protein kinase D1 | Homo sapiens (Human) | EV |
Q8BZ03 | Prkd2 | Serine/threonine-protein kinase D2 | Mus musculus (Mouse) | SS |
Q8K1Y2 | Prkd3 | Serine/threonine-protein kinase D3 | Mus musculus (Mouse) | SS |
Q62101 | Prkd1 | Serine/threonine-protein kinase D1 | Mus musculus (Mouse) | SS |
Q5XIS9 | Prkd2 | Serine/threonine-protein kinase D2 | Rattus norvegicus (Rat) | SS |
O45818 | dkf-2 | Serine/threonine-protein kinase dkf-2 | Caenorhabditis elegans | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MSAPPLLRPP | SPLLPAAAAV | AAAAAALVPG | SGPAPFPAPG | AAPAGGISFH | LQIGLSREPV |
70 | 80 | 90 | 100 | 110 | 120 |
LLLQDSSGDY | SLAHVREMAC | SIVDQKFPEC | GFYGLYDKIL | LFRHDPASEN | ILQLVKIASD |
130 | 140 | 150 | 160 | 170 | 180 |
IQEGDLIEVV | LSASATFEDF | QIRPHALFVH | SYRAPAFCDH | CGEMLWGLVR | QGLKCEGCGL |
190 | 200 | 210 | 220 | 230 | 240 |
NYHKRCAFKI | PNNCSGVRRR | RLSNVSLTGL | GTVRTASAEF | STSAPDEPLL | SPVSPGFEQK |
250 | 260 | 270 | 280 | 290 | 300 |
SPSESFIGRE | KRSNSQSYVG | RPIQLDKLLM | SKVKVPHTFV | IHSYTRPTVC | QFCKKLLKGL |
310 | 320 | 330 | 340 | 350 | 360 |
FRQGLQCKDC | RFNCHKRCAP | KVPNNCLGEV | TINGELLSPG | AESDVVMEEG | SDDNDSERNS |
370 | 380 | 390 | 400 | 410 | 420 |
GLMDDMDEAM | VQDTEMALAE | GQSDGAEMQD | PDADQEDSNR | TISPSTSNNI | PLMRVVQSVK |
430 | 440 | 450 | 460 | 470 | 480 |
HTKRRSSTVM | KEGWMVHYTS | KDTLRKRHYW | RLDSKSITLF | QNDTGSRYYK | EIPLSEILCL |
490 | 500 | 510 | 520 | 530 | 540 |
EPAKPSALIP | TGANPHCFEI | TTANVVYYVG | ENVVNPSSPP | PNNSVPPSGI | GTDVARMWEV |
550 | 560 | 570 | 580 | 590 | 600 |
AIQHALMPVI | PKGSSVGSGT | NSHKDISVSI | SVSNSQIQEN | VDISTVYQIF | PDEVLGSGQF |
610 | 620 | 630 | 640 | 650 | 660 |
GIVYGGKHRK | TGRDVAIKII | DKLRFPTKQE | SQLRNEVAIL | QNLHHPGVVN | LECMFETPER |
670 | 680 | 690 | 700 | 710 | 720 |
VFVVMEKLHG | DMLEMILSSE | KGRLPEHITK | FLITQILVAL | RHLHFKNIVH | CDLKPENVLL |
730 | 740 | 750 | 760 | 770 | 780 |
ASADPFPQVK | LCDFGFARII | GEKSFRRSVV | GTPAYLAPEV | LRNKGYNRSL | DMWSVGVIIY |
790 | 800 | 810 | 820 | 830 | 840 |
VSLSGTFPFN | EDEDIHDQIQ | NAAFMYPPNP | WKEISHEAID | LINNLLQVKM | RKRYSVDKTL |
850 | 860 | 870 | 880 | 890 | 900 |
SHPWLQDYQT | WLDLRELECR | IGERYITHES | DDSRWEQYAG | EQGLQYPAHL | INLSASHGDS |
910 | |||||
PEAEEREMKA | LSERVSIL |